Firefly Neuroscience (AIFF) Capital Expenditures Growth (5y) (2015 - 2026)
Powered by 
Analysis
Firefly Neuroscience (AIFF) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.68% |
| Mar 31, 2026 | 65.92% |
| Dec 31, 2025 | 31.24% |
| Sep 30, 2025 | 11.53% |
| Sep 30, 2024 | 118.42% |
| Jun 30, 2024 | 60.74% |
| Dec 31, 2022 | 224.41% |
| Dec 31, 2021 | 49.57% |
| Sep 30, 2021 | 78.07% |
| Jun 30, 2021 | 47.58% |
| Mar 31, 2021 | -8.42% |
| Dec 31, 2020 | -4.67% |
| Sep 30, 2020 | 99.10% |
| Dec 31, 2019 | -37.96% |
| Sep 30, 2019 | -15.62% |
| Jun 30, 2019 | 5.84% |
| Dec 31, 2018 | 20.56% |
| Sep 30, 2018 | -45.35% |
| Jun 30, 2018 | -58.10% |
| Mar 31, 2018 | -1.10% |